News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
LEVINE EVAN
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/03/2018 |
4
| LEVINE EVAN (CEO) has filed a Form 4 on Probility Media Corp|
Txns:
| Granted 77,777,778 shares
@ $0.0009, valued at
$70k
|
|
| 02/21/2017 |
4
| LEVINE EVAN (CEO) has filed a Form 4 on Probility Media Corp |
| 02/21/2017 |
3
| LEVINE EVAN (CEO) has filed a Form 3 on Probility Media Corp |
| 03/01/2010 |
4
| LEVINE EVAN (Director) has filed a Form 4 on NURX PHARMACEUTICALS, INC.|
Txns:
| Gifted 11,500 shares
@ $0
Granted 50,000 options to buy
@ $0.45, valued at
$22.5k
|
|
| 02/09/2010 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2010 |
SC 13G
| LEVINE EVAN reports a 5.7% stake in Nurx Pharmaceuticals, Inc. |
| 06/18/2009 |
3
| LEVINE EVAN (Director) has filed a Form 3 on NURX PHARMACEUTICALS, INC. |
| 02/13/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/06/2009 |
SC 13D/A
| LEVINE EVAN has filed a Schedule 13D for ADVENTRX Pharmaceuticals, Inc. |
| 10/10/2008 |
SC 13D/A
| LEVINE EVAN reports a 0% stake in SILVERGRAPH INTERNATIONAL, INC. |
| 04/15/2008 |
4
| LEVINE EVAN (CEO & President) has filed a Form 4 on ADVENTRX PHARMACEUTICALS INC|
Txns:
| Bought 3,000 shares
@ $0.51, valued at
$1.5k
Bought 2,000 shares
@ $0.5, valued at
$1k
|
|
| 04/15/2008 |
4
| LEVINE EVAN (CEO & President) has filed a Form 4 on ADVENTRX PHARMACEUTICALS INC|
Txns:
| Bought 2,300 shares
@ $1.19, valued at
$2.7k
Bought 700 shares
@ $1.19, valued at
$833
Bought 100 shares
@ $0.93, valued at
$93
Bought 500 shares
@ $0.93, valued at
$465
Bought 1,500 shares
@ $0.93, valued at
$1.4k
Bought 400 shares
@ $0.93, valued at
$372
Bought 1,800 shares
@ $0.86, valued at
$1.5k
Sold 3,000 shares
@ $1.5, valued at
$4.5k
Sold 3,800 shares
@ $3.16, valued at
$12k
Sold 1,200 shares
@ $3.22, valued at
$3.9k
Bought 900 shares
@ $3.86, valued at
$3.5k
|
|
| 12/19/2007 |
SC 13D/A
| LEVINE EVAN has filed a Schedule 13D for ADVENTRX Pharmaceuticals, Inc. |
| 12/17/2007 |
4
| LEVINE EVAN (CEO & Director) has filed a Form 4 on ADVENTRX PHARMACEUTICALS INC|
Txns:
| Bought 50,000 shares
@ $0.44, valued at
$22k
Bought 10,000 shares
@ $0.48, valued at
$4.8k
|
|
| 11/29/2007 |
SC 13G/A
| LEVINE EVAN has filed a Schedule 13D for QuantRx Biomedical Corporation |
| 03/29/2007 |
SC 13D/A
| LEVINE EVAN has filed a Schedule 13D for QUANTRX BIOMEDICAL CORPORATION |
| 02/09/2007 |
4
| LEVINE EVAN (10% Owner) has filed a Form 4 on QUANTRX BIOMEDICAL CORP|
Txns:
| Sold 70,000 shares
@ $0.7, valued at
$49k
Sold 50,000 shares
@ $0.7, valued at
$35k
Sold 25,000 shares
@ $0.7, valued at
$17.5k
Sold 400,000 shares
@ $0.7, valued at
$280k
Sold 53,009 shares
@ $0.7, valued at
$37.1k
Sold 200,000 shares
@ $0.7, valued at
$140k
|
|
| 07/07/2006 |
SC 13D
| LEVINE EVAN reports a 13.4% stake in SILVERGRAPH INTERNATIONAL, INC. |
| 06/30/2006 |
4
| LEVINE EVAN (President & CEO) has filed a Form 4 on ADVENTRX PHARMACEUTICALS INC|
Txns:
| Exercised (in-or-at-the-money) 25,000 options to buy
@ $0.5, valued at
$12.5k
|
|
| 06/28/2006 |
4
| LEVINE EVAN (President & CEO) has filed a Form 4 on ADVENTRX PHARMACEUTICALS INC|
Txns:
| Exercised (in-or-at-the-money) 25,000 options to buy
@ $0.5, valued at
$12.5k
|
|
| 06/27/2006 |
4
| LEVINE EVAN (President & CEO) has filed a Form 4 on ADVENTRX PHARMACEUTICALS INC|
Txns:
| Exercised (in-or-at-the-money) 25,000 options to buy
@ $0.5, valued at
$12.5k
|
|
| 06/23/2006 |
4
| LEVINE EVAN (President & CEO) has filed a Form 4 on ADVENTRX PHARMACEUTICALS INC|
Txns:
| Exercised (in-or-at-the-money) 25,000 options to buy
@ $0.5, valued at
$12.5k
|
|
| 04/25/2006 |
4
| LEVINE EVAN (President & CEO) has filed a Form 4 on ADVENTRX PHARMACEUTICALS INC|
Txns:
| Exercised (in-or-at-the-money) 25,601 options to buy
@ $0.5, valued at
$12.8k
|
|
| 09/14/2005 |
4
| LEVINE EVAN (President and CEO) has filed a Form 4 on ADVENTRX PHARMACEUTICALS INC|
Txns:
| Sold 1,000 shares
@ $3.64, valued at
$3.6k
Sold 4,600 shares
@ $3.62, valued at
$16.7k
Sold 1,100 shares
@ $3.61, valued at
$4k
Sold 19,599 shares
@ $3.6, valued at
$70.6k
Sold 28,100 shares
@ $3.5, valued at
$98.4k
Exercised (in-or-at-the-money) 54,399 options to buy
@ $0.5, valued at
$27.2k
|
|
| 10/21/2002 |
SC 13D
| LEVINE EVAN reports a 21.9% stake in Biokeys Pharmaceuticals, Inc. |
|
|